Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Taiwan's TLC Reports Positive Data on Long-Acting Steroid for Arthritis

publication date: Jan 6, 2017
TLC (Taiwan Liposome Company) reported positive top-line results from the Phase I/II trial of TLC599, a sustained release corticosteroid. From baseline to week 12, the candidate demonstrated a trend of clinically meaningful reduction in pain among patients with arthritis of the knee, using several widely-used assessments of pain. TLC explains that, for safety reasons, corticosteroids can be used only once every three months, but their beneficial effect lasts for just two weeks. TLC used its proprietary BioSeizer platform to create the sustained release formula. More details....

Stock Symbol: (TT: 4152)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital